Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,241 | -55,178 | -30,055 | -21,561 | -16,945 |
| Depreciation Amortization | 138 | 146 | 149 | 173 | 389 |
| Accounts receivable | 11,687 | -15,000 | N/A | 7 | 461 |
| Accounts payable and accrued liabilities | 1,652 | 3,031 | 500 | -90 | -102 |
| Other Working Capital | -2,572 | 8,215 | -1,369 | 567 | 836 |
| Other Operating Activity | -9,712 | 15,173 | 2,222 | 964 | -3,111 |
| Operating Cash Flow | $-55,048 | $-43,613 | $-28,553 | $-19,940 | $-18,472 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -97,635 | -129,977 | -198,912 | -25,472 | -3,399 |
| PPE Investments | -267 | -64 | -376 | -23 | 2,096 |
| Sale Of Investment | 107,565 | 157,433 | 127,967 | 14,300 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -5 |
| Investing Cash Flow | $9,663 | $27,392 | $-71,321 | $-11,195 | $-1,308 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -5,082 | N/A | -14,340 |
| Common Stock Issued | 60,376 | 327 | 116,414 | 16,837 | 958 |
| Other Financing Activity | 0 | 0 | 0 | 4,245 | 14,330 |
| Financing Cash Flow | $60,376 | $327 | $111,332 | $21,082 | $948 |
| Beginning Cash Position | 15,369 | 31,263 | 19,805 | 29,858 | 29,096 |
| End Cash Position | 30,360 | 15,369 | 31,263 | 19,805 | 10,264 |
| Net Cash Flow | $14,991 | $-15,894 | $11,458 | $-10,053 | $-18,832 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,048 | -43,613 | -28,553 | -19,940 | -18,472 |
| Capital Expenditure | -267 | -64 | -376 | -23 | -468 |
| Free Cash Flow | -55,315 | -43,677 | -28,929 | -19,963 | -18,940 |